CAMCEVI Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Camcevi, and what generic alternatives are available?
Camcevi is a drug marketed by Accord and is included in two NDAs. There are five patents protecting this drug.
The generic ingredient in CAMCEVI is leuprolide mesylate. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the leuprolide mesylate profile page.
DrugPatentWatch® Generic Entry Outlook for Camcevi
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CAMCEVI?
- What are the global sales for CAMCEVI?
- What is Average Wholesale Price for CAMCEVI?
Summary for CAMCEVI
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Drug Prices: | Drug price information for CAMCEVI |
| What excipients (inactive ingredients) are in CAMCEVI? | CAMCEVI excipients list |
| DailyMed Link: | CAMCEVI at DailyMed |
US Patents and Regulatory Information for CAMCEVI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord | CAMCEVI ETM | leuprolide mesylate | EMULSION;SUBCUTANEOUS | 219745-001 | Aug 25, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Accord | CAMCEVI KIT | leuprolide mesylate | EMULSION;SUBCUTANEOUS | 211488-001 | May 25, 2021 | RX | Yes | Yes | 9,744,207 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Accord | CAMCEVI KIT | leuprolide mesylate | EMULSION;SUBCUTANEOUS | 211488-001 | May 25, 2021 | RX | Yes | Yes | 10,646,572 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Accord | CAMCEVI KIT | leuprolide mesylate | EMULSION;SUBCUTANEOUS | 211488-001 | May 25, 2021 | RX | Yes | Yes | 11,717,555 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Accord | CAMCEVI KIT | leuprolide mesylate | EMULSION;SUBCUTANEOUS | 211488-001 | May 25, 2021 | RX | Yes | Yes | 9,572,857 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Accord | CAMCEVI KIT | leuprolide mesylate | EMULSION;SUBCUTANEOUS | 211488-001 | May 25, 2021 | RX | Yes | Yes | 12,133,878 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
